Drug Profile
Research programme: renal failure therapy - NitroMed/Universities of Edinburgh and St Andrews
Latest Information Update: 29 Mar 2007
Price :
$50
*
At a glance
- Originator NitroMed; University of Edinburgh; University of St Andrews
- Developer University of Edinburgh; University of St Andrews
- Class
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Renal failure
Most Recent Events
- 09 Feb 2004 Preclinical trials in Renal failure in Scotland (unspecified route)